Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
7.56
0.00 (0.00%)
Jun 8, 2026, 4:00 PM EDT - Market closed
CRBP Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 25.66 | 28.49 | 17.2 | 13.72 | 17 | 25.01 |
Short-Term Investments | 112.56 | 134.78 | 131.86 | 7.18 | 42.19 | 72.64 |
Cash & Short-Term Investments | 138.22 | 163.27 | 149.06 | 20.91 | 59.2 | 97.65 |
Cash Growth | 4.09% | 9.53% | 613.01% | -64.68% | -39.38% | 14.30% |
Other Current Assets | 5.35 | 3.69 | 3.91 | 2.64 | 0.98 | 2.56 |
Total Current Assets | 143.57 | 166.95 | 152.98 | 23.55 | 60.18 | 100.21 |
Net Property, Plant & Equipment | 0.91 | 1.24 | 2.52 | 4.04 | 5.5 | 7 |
Other Long-Term Assets | - | - | 0.39 | 0.69 | 0.63 | 0.52 |
Total Assets | 144.48 | 168.2 | 155.88 | 28.27 | 66.31 | 107.73 |
Accounts Payable | 0.44 | 2.22 | 4.79 | 3.18 | 2.17 | 1.78 |
Accrued Expenses | 16.5 | 16.84 | 5.43 | 11.03 | 6 | 10.09 |
Short-Term Debt | - | - | - | 16.21 | 0.35 | 0.77 |
Current Portion of Long-Term Debt | - | - | - | - | 2.8 | 3.09 |
Current Portion of Leases | 1.21 | 1.63 | 1.61 | 1.44 | 1.28 | 1.14 |
Other Current Liabilities | - | - | - | 0.04 | 0.04 | 0.13 |
Total Current Liabilities | 18.14 | 20.69 | 11.82 | 31.89 | 12.64 | 17.01 |
Long-Term Debt | - | - | - | - | 15.98 | 15.64 |
Long-Term Leases | - | - | 1.63 | 3.24 | 4.68 | 5.96 |
Other Long-Term Liabilities | - | - | - | 0.04 | 0.02 | 0.02 |
Total Long-Term Liabilities | - | - | 1.63 | 3.28 | 20.68 | 21.61 |
Total Liabilities | 18.14 | 20.69 | 13.45 | 35.18 | 33.32 | 38.62 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 704.9 | 702.98 | 619.29 | 429.78 | 425.2 | 418.9 |
Accumulated Other Comprehensive Income | -0.16 | -0.05 | 0.04 | -0 | -0.13 | -0.06 |
Retained Earnings | -578.4 | -555.43 | -476.89 | -436.68 | -392.08 | -349.73 |
Shareholders' Equity | 126.34 | 147.5 | 142.43 | -6.91 | 32.99 | 69.11 |
Total Liabilities & Equity | 144.48 | 168.2 | 155.88 | 28.27 | 66.31 | 107.73 |
Total Debt | 1.21 | 1.63 | 3.24 | 20.89 | 25.09 | 26.59 |
Net Cash (Debt) | 137.01 | 161.64 | 145.82 | 0.02 | 34.11 | 71.06 |
Net Cash Growth | -15.23% | 10.84% | 694295.24% | -99.94% | -52.00% | 21.26% |
Net Cash Per Share | 0.04 | 12.14 | 13.36 | 0.01 | 8.18 | 17.35 |
Book Value | 126.34 | 147.5 | 142.43 | -6.91 | 32.99 | 69.11 |
Book Value Per Share | 0.04 | 11.08 | 13.05 | -1.60 | 7.91 | 16.88 |
Tangible Book Value | 126.34 | 147.5 | 142.43 | -6.91 | 32.99 | 69.11 |
Tangible Book Value Per Share | 0.04 | 11.08 | 13.05 | -1.60 | 7.91 | 16.88 |